Stephens Upgrades Neogenomics (NEO) to Overweight

Stephens analyst Mason Carrico upgraded Neogenomics (NASDAQ: NEO) from Equal Weight to Overweight with a price target of $18.00 (from $16.00).

For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.

Shares of Neogenomics closed at $13.55 yesterday.

You May Also Be Interested In

• Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
• Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
• Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley